| Thursday, October 22, 2020
| |
|
CF Foundation Commits up to $14M to Expand Agreement with Synspira Therapeutics
This week, the Foundation announced it’s expanding its research collaboration with Synspira Therapeutics, committing up to $14 million in additional funding to develop a pancreatic enzyme replacement therapy and a new treatment to help fight drug-resistant infections. If successful, the enzyme therapy could offer a more effective alternative to people with cystic fibrosis who struggle with digestion. In addition to fighting infections, the novel treatment could also reduce inflammation in the lungs and thin mucus.
| |
Celebrate Holidays SafelyCelebrating the holidays with friends and family is something that people with cystic fibrosis need to approach with caution under the best of circumstances. The COVID-19 pandemic makes staying safe this holiday season more complicated. We've updated our COVID-19 community Q&A to include information about the factors that affect your risk as you consider how — and with whom — to celebrate the holidays.
| |
Together: Now Available on YouTube The recording from Together: Now, our virtual event celebrating the cystic fibrosis community, is now available. Watch as special guests including NFL quarterback Joe Flacco, former Bachelorette Becca Kufrin, and adults living with CF share their stories as we celebrate the many ways the CF community tackled the 65 Roses Challenge together.
Watch the recording »
| |
Hitting the Reset Button on My Life Because of Trikafta As a 28-year-old living with cystic fibrosis, Bridget McGarey, has had more than 40 two-week hospitalizations since her teens. But after starting Trikafta last year, she shares how the CFTR modulator has helped her feel like she can reset the clock and start living her life.
| |
|
|
|
|
